Good example of sarcasm, almost as good as the "EichSho-LMFAO" twins. (sounds like you'd like to see investors "dumping", I'm hoping for the opposite, maybe that's because I am an INVESTOR!)
WRONG!! The most important "piece of this puzzle" is proving in the clinic that the science and predicted MOA of the cells does in fact benefit the patient.
Unfortunately the obsessive concern over management going to conferences (an absolute necessity for all small companies) blots out all awareness of the forward momentum in the regulatory arena, corroboration by multiple scientific papers, and recognition by private and government agencies and the ongoing expansion of Pluristem's patent portfolio (which IS the basis for whatever value this company will have, ESSENTIAL!!!!).
I'm continuing to buy, I'm getting past 100K, hoping to get to 200K before the pps shoots upward. At this level it's irresistible!